Copertina

Anti‐D prophylaxis should protect all newborns from haemolytic disease, regardless of their country of residence

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Marcela Contreras, Belinda Kumpel, Natalia Olovnikova
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Vox Sanguinis
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The contemporary management of haemolytic disease of the fetus and newborn
di: Mark D. Kilby, et al.
Pubblicazione: (2025)

Efficacy of intravenous immunoglobulin following plasma exchange in the management of ABO haemolytic disease of the newborn
di: Yahong Hu, et al.
Pubblicazione: (2026)

Cost‐effectiveness of cEK ‐preventive matched transfusion strategies for female transfusion recipients to prevent haemolytic disease of the foetus and newborn in the Dutch healthcare setting
di: Jessie S. Luken, et al.
Pubblicazione: (2026)

Pre‐exposure prophylaxis use in blood donors in England
di: Jaid Debrah, et al.
Pubblicazione: (2026)

Blood donor questionnaires and infectious disease screening in Latin American countries
di: Gisela Marrero‐Rivera, et al.
Pubblicazione: (2024)

Non‐invasive foetal RhD genotyping: A strategy for rationalizing anti‐D immunoglobulin prophylaxis in RhD ‐negative pregnant women at the Hospital Italiano de Buenos Aires
di: Diego Mario Santoro, et al.
Pubblicazione: (2025)

Does high body mass index (>25 kg/m2) or weight (>80 kg) reduce the effectiveness of anti‐D prophylaxis in Rh(D)‐negative pregnant women? A systematic review and meta‐analysis
di: C. B. M. Ngan, et al.
Pubblicazione: (2024)

Has the switch to sexual risk behaviour screening impacted deferrals for pre‐ and post‐exposure prophylaxis therapy for human immunodeficiency virus?
di: Mindy Goldman, et al.
Pubblicazione: (2024)

How much furosemide should be administered to prevent transfusion‐associated circulatory overload? Results of a dose‐finding study
di: Lianne Rotin, et al.
Pubblicazione: (2025)

Estimated Plasmodium18S ribosomal RNA prevalence in asymptomatic blood donors from three African countries
di: Laura Tonnetti, et al.
Pubblicazione: (2024)

Potential benefits of an alternative haemoglobin deferral strategy evaluated in seven countries
di: Amber Meulenbeld, et al.
Pubblicazione: (2025)

Correction to ‘Potential benefits of an alternative haemoglobin deferral strategy evaluated in seven countries’
Pubblicazione: (2026)

Efficacy of communication interventions for promoting blood donation in low‐ and middle‐income countries: A systematic review
di: Bernard Appiah, et al.
Pubblicazione: (2025)

Protection of fundamental human rights by improving patient access to plasma‐derived therapies and donor health protection
di: Jean‐Baptiste Thibert, et al.
Pubblicazione: (2026)

Response to comments from the International Patient Organization for Primary Immunodeficiencies on ‘Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries’
di: Thierry Burnouf, et al.
Pubblicazione: (2024)

Impact of conflict/war disasters on blood banks and transfusion services in low‐ and middle‐income countries in the Eastern Mediterranean region
di: Arwa Z. Al‐Riyami, et al.
Pubblicazione: (2025)

Using unmanned aerial vehicles (drones) to improve access to blood in low‐ and middle‐income countries: Current challenges and opportunities
di: Suvro Sankha Datta, et al.
Pubblicazione: (2026)

Anti‐monkeypox virus‐neutralizing activities of human immunoglobulin manufactured between 1999 and 2021 and derived from donors in the United States and Japan
di: Mikihiro Yunoki, et al.
Pubblicazione: (2024)

Immunoglobulin solutions for patients with primary immunodeficiency. Comments on Burnouf et al.'s ‘Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries’
di: Martine Pergent, et al.
Pubblicazione: (2024)

Demographics and donor motivation drive declining blood donations: A 15‐year study in Germany reflecting trends in high‐income countries
di: Sophia Oesterreicher, et al.
Pubblicazione: (2026)

RhD mismatch does not affect haematopoietic recovery, graft‐versus‐host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry‐based study
di: Takaaki Konuma, et al.
Pubblicazione: (2024)

Current state of gene therapy in sickle cell disease
di: Mei San Tang, et al.
Pubblicazione: (2024)

Analysis of wrong blood in tube events at a hospital‐based blood centre in a tertiary care referral hospital: A perspective from a lower middle‐income country
di: Aparna Krishna, et al.
Pubblicazione: (2024)

Introduction of 7‐day amotosalen/ultraviolet A light pathogen‐reduced platelets in Honduras: Impact on platelet availability in a lower middle‐income country
di: Marcelo Pedraza, et al.
Pubblicazione: (2024)

Chagas disease in Canadian blood donors: 15 years of selective testing
di: Sheila F. O'Brien, et al.
Pubblicazione: (2026)

Transfusion‐associated acute lung injury following albumin treatment in liver disease
di: Hussam Al Hennawi, et al.
Pubblicazione: (2024)

Viscoelastic haemostatic assays in chronic liver disease—Profiling coagulation in the emergency department
di: Akmez Latona, et al.
Pubblicazione: (2025)

Transfusion‐associated graft‐versus‐host disease and purine analogues: What are we missing?
di: Chin Zhong Ng, et al.
Pubblicazione: (2025)

Quality of life in people with sickle cell disease treated with automated red blood cell exchange
di: Koenraad Dierick, et al.
Pubblicazione: (2024)

Evaluating alloimmunization risk in patients with sickle cell disease and in prenatal care patients with RHCE variants
di: Gabriel André Leiva‐Torres, et al.
Pubblicazione: (2026)

Removal of deferrals for variant Creutzfeldt–Jakob disease risk: Impact on new and previously deferred donors
di: Mindy Goldman, et al.
Pubblicazione: (2025)

Partial D variant with demonstrated risk of D alloimmunization in the Australian Indigenous population
di: Emma Palfreyman, et al.
Pubblicazione: (2025)

An international survey on measures to prevent transfusion‐transmitted infectious diseases—study results 1: Participation rates and the presence of laws, regulations, standards and best practices
di: Galen Conti, et al.
Pubblicazione: (2025)

Achieving sustainable anti‐ D immunoprophylaxis in Europe
di: Pierre Tiberghien, et al.
Pubblicazione: (2026)

Prediction of the antigenic regions in eight RhD variants identified by computational biology
di: Rocio Trueba‐Gómez, et al.
Pubblicazione: (2024)

Use and availability of anti‐ RhD immunoglobulin in Colombia following the 2024 national shortage
di: Mariana Barake‐Ramos, et al.
Pubblicazione: (2026)

Incidence of formation of anti‐D between patients with and without a history of solid organ transplant
di: Junaid Ahmad Wali, et al.
Pubblicazione: (2024)

Routine maternal ABO/Rhesus D blood typing can alert of massive foetomaternal haemorrhage
di: Lilach Bonstein, et al.
Pubblicazione: (2024)

A novel RHD allele (c.727 T>G) associated with reduced D antigen expression in a pregnant Chinese woman
di: Ning Li, et al.
Pubblicazione: (2026)

Real‐world performance of a clinical droplet digital polymerase chain reaction assay for non‐invasive foetal blood group and platelet antigen genotyping of alloimmunized pregnant women with antibodies directed against RhD, RhE, Rhc, RhC, K1, HPA‐1a or HPA‐5b: A 1‐year experience
di: Camilla Calandrini, et al.
Pubblicazione: (2024)